We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,338.00
Bid: 1,326.00
Ask: 1,342.00
Change: -26.00 (-1.91%)
Spread: 16.00 (1.207%)
Open: 1,362.00
High: 1,362.00
Low: 1,312.00
Prev. Close: 1,364.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

9 Aug 2023 10:52

RNS Number : 8098I
Georgia Capital PLC
09 August 2023
 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 (THE "MARKET ABUSE REGULATION")

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY JURISDICTION IN WHICH, OR TO ANY PERSON TO OR FROM WHOM, IT IS UNLAWFUL UNDER APPLICABLE LAWS TO DISTRIBUTE THIS ANNOUNCEMENT.

 

9 August 2023

JSC GEORGIA CAPITAL ANNOUNCES RESULTS OF TENDER OFFER TO PURCHASE NOTES FOR CASH 

JSC Georgia Capital (the "Issuer") announces today the results of the tender offer that the Issuer commenced on 12 July 2023, for its outstanding U.S.$300,000,000[1] 6.125% notes due 2024 (the "Notes"), for cash (the "Tender Offer"). The terms of the Tender Offer are described in a tender offer memorandum dated 12 July 2023 (the "Tender Offer Memorandum").

Capitalised terms used in this announcement but not otherwise defined have the meanings given to them in the Tender Offer Memorandum.

Results of the Tender Offer

The Tender Offer expired at 11:59 p.m. (New York time) on 8 August 2023. The following table sets forth the results of the Tender Offer, including the aggregate principal amount of Notes accepted for purchase and the Purchase Price per U.S. $1,000 in principal amount of Notes accepted for purchase in the Tender Offer, as determined in accordance with the terms as set out in the Tender Offer Memorandum.

Description of the Notes

ISIN/Common Code/CUSIP

Minimum Denomination

Benchmark Reference Security Yield

Repurchase Yield

Purchase Price

Aggregate Principal Amount of Notes accepted for purchase

U.S.$300,000,000 6.125% notes

Regulation S Notes ISIN XS1778929478/ Common Code: 177892947

Rule 144A Notes ISIN US373143AA49/ Common Code 178546554/ CUSIP 373143AA4

U.S.$200,000 and integral multiples of U.S.$1,000 thereafter

5.424%

5.924%

U.S.$1,001.07 per U.S.$1,000 in principal amount of the Notes

U.S.$176,521,000

New Financing Condition

The Issuer confirms that the New Financing Condition has been satisfied.

Payment of the Purchase Price and the Accrued Interest Amount

The Issuer will also pay an Accrued Interest Payment in respect of any Notes accepted for purchase pursuant to the Tender Offer, as further described in the Tender Offer Memorandum.

The Purchase Price and the Accrued Interest Amount for the Notes accepted for purchase in the Tender Offer will each be paid on the Payment Date, which is expected to be on or about 10 August 2023.

Future Actions in Respect of the Notes

The Issuer intends to cancel U.S.$176,521,000 in aggregate principal amount of the Notes it accepts for purchase pursuant to the Tender Offer and U.S.$106,878,000 in aggregate principal amount owned by the Issuer. Following settlement of the Tender Offer and the cancellation of U.S.$283,399,000 in aggregate principal amount of the Notes, U.S.$16,601,000 in aggregate principal amount of the Notes will remain outstanding.

Following such cancellation, the Issuer intends to exercise its right to redeem any Notes not acquired in the Tender Offer pursuant to the optional redemption and make whole provision contained in "Terms and Conditions of the Notes-Condition 6(c) (Optional Redemption at Make Whole)" in the listing particulars pursuant to which the Notes were issued.

Further Information

A complete description of the terms and conditions of the Tender Offer is set out in the Tender Offer Memorandum.

Requests for information in relation to the Tender Offer should be directed to:

The Dealer Manager

J.P. Morgan Securities plc

25 Bank Street

Canary Wharf

London E14 5JP

United Kingdom

 

Email: em_europe_lm@jpmorgan.com

Attention: Liability Management

Tel: +44 20 7134 2468

The Tender and Information Agent

Kroll Issuer Services Limited

The Shard32 London Bridge StreetLondon SE1 9SG

United Kingdom

 

Attention: Jacek Kusion

Tel: +44 20 7704 0880

Email: gcap@is.kroll.com

Website: https://deals.is.kroll.com/gcap

 

DISCLAIMER

This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire or exchange any notes is being made pursuant to this announcement. This announcement and the Tender Offer Memorandum contain important information, which must be read carefully. If any Noteholder is in any doubt as to the contents of this announcement or the Tender Offer Memorandum or the action it should take, it is recommended to seek its own legal, tax and financial advice, including as to any tax consequences, immediately from its stockbroker, bank manager, solicitor, accountant or other independent financial adviser. None of the Issuer, the Dealer Manager, the Tender and Information Agent, or any person who controls, or is a director, officer, employee or agent of such persons, or any affiliate of such persons, makes any representation or recommendation whatsoever regarding this announcement, the Tender Offer Memorandum or the Tender Offer.

 

This announcement is released by JSC Georgia Capital and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation, encompassing information relating to the Tender Offer described above. For the purposes of the Market Abuse Regulation, this announcement is made by Giorgi Alpaidze, the Chief Financial Officer of JSC Georgia Capital.


[1] In October 2022, the Issuer repurchased and cancelled U.S.$65 million Notes, decreasing the outstanding principal amount from U.S.$365 million to U.S.$300 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEUKSKROKUWRRR
Date   Source Headline
1st May 20247:00 amRNS1st Quarter Results
24th Apr 202412:30 pmRNSNotice of Results
12th Apr 20247:00 amRNSNotice of AGM
8th Apr 202410:52 amRNSChange of Registered Office
3rd Apr 20245:29 pmRNSDirector/PDMR Shareholding
25th Mar 20245:29 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSAnnual Financial Report
14th Mar 20245:13 pmRNSDirector/PDMR Shareholding
29th Feb 202410:13 amRNSCancellation of Treasury Shares
28th Feb 20247:00 amRNSDirector/PDMR Shareholding
23rd Feb 20243:58 pmEQSEdison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms
23rd Feb 20241:13 pmRNSTransaction in Own Shares
22nd Feb 20245:23 pmRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSFinal Results
21st Feb 20245:58 pmRNSTransaction in Own Shares
20th Feb 20245:18 pmRNSTransaction in Own Shares
19th Feb 20242:19 pmRNSTransaction in Own Shares
16th Feb 20244:29 pmRNSTransaction in Own Shares
15th Feb 20244:24 pmRNSTransaction in Own Shares
15th Feb 20243:15 pmRNSNotice of Results
14th Feb 20245:05 pmRNSTransaction in Own Shares
13th Feb 20243:19 pmRNSTransaction in Own Shares
9th Feb 20245:12 pmRNSTransaction in Own Shares
8th Feb 20245:17 pmRNSTransaction in Own Shares
7th Feb 20244:45 pmRNSTransaction in Own Shares
6th Feb 20243:23 pmRNSTransaction in Own Shares
5th Feb 20244:48 pmRNSTransaction in Own Shares
2nd Feb 20241:40 pmRNSTransaction in Own Shares
1st Feb 20244:57 pmRNSTransaction in Own Shares
1st Feb 202411:49 amRNSTotal Voting Rights
31st Jan 20245:03 pmRNSCancellation of Treasury Shares
31st Jan 20244:48 pmRNSTransaction in Own Shares
30th Jan 20243:26 pmRNSTransaction in Own Shares
29th Jan 20242:28 pmRNSTransaction in Own Shares
26th Jan 20245:32 pmRNSTransaction in Own Shares
25th Jan 20244:27 pmRNSTransaction in Own Shares
24th Jan 20243:25 pmRNSTransaction in Own Shares
23rd Jan 20241:58 pmRNSHolding(s) in Company
23rd Jan 202412:09 pmRNSTransaction in Own Shares
22nd Jan 20245:26 pmRNSTransaction in Own Shares
19th Jan 20243:55 pmRNSTransaction in Own Shares
19th Jan 20242:45 pmRNSDirector/PDMR Shareholding
18th Jan 20244:00 pmRNSTransaction in Own Shares
17th Jan 20245:20 pmRNSTransaction in Own Shares
16th Jan 20244:19 pmRNSTransaction in Own Shares
15th Jan 20245:14 pmRNSTransaction in Own Shares
12th Jan 20243:05 pmRNSTransaction in Own Shares
11th Jan 20243:54 pmRNSTransaction in Own Shares
10th Jan 20244:19 pmRNSTransaction in Own Shares
9th Jan 20245:28 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.